News - Afexa Life Sciences

Filter

Current filters:

Afexa Life Sciences

Popular Filters

Valeant out-bids Paladin with C$76 million cash bid for Afexa

31-08-2011

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says that it has entered…

Afexa Life SciencesMergers & AcquisitionsPaladin LabsPharmaceuticalValeant Pharmaceuticals

Back to top